Monitoring nonadherence and acute rejection with variation in blood immunosuppressant levels in pediatric renal transplantation

scientific article published on 01 October 2011

Monitoring nonadherence and acute rejection with variation in blood immunosuppressant levels in pediatric renal transplantation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/TP.0B013E31822DC34F
P698PubMed publication ID21857278

P50authorHilda FernandezQ81116914
P2093author name stringRobert B Ettenger
David Gjertson
Eileen W Tsai
Margaret Hsiau
P433issue8
P407language of work or nameEnglishQ1860
P304page(s)918-922
P577publication date2011-10-01
P1433published inTransplantationQ15730500
P1476titleMonitoring nonadherence and acute rejection with variation in blood immunosuppressant levels in pediatric renal transplantation
P478volume92

Reverse relations

cites work (P2860)
Q64991007A Novel, Dose-Adjusted Tacrolimus Trough-Concentration Model for Predicting and Estimating Variance After Kidney Transplantation.
Q92803551Adherence Behavior in Subjects on Hemodialysis Is Not a Clear Predictor of Posttransplantation Adherence
Q92043461Adherence is associated with a favorable outcome after lung transplantation
Q104584018Age and sex determine conversion from immediate-release to extended-release tacrolimus in a multi-center cohort of Canadian pediatric renal transplant recipients
Q92008032Association of Intrapatient Variability of Tacrolimus Concentration With Early Deterioration of Chronic Histologic Lesions in Kidney Transplantation
Q48307185Bioequivalence of twice-daily oral tacrolimus in transplant recipients: More evidence for consensus?
Q46684824Concepts of Genomics in Kidney Transplantation
Q47577281Efficacy of Prolonged- and Immediate-release Tacrolimus in Kidney Transplantation: A Pooled Analysis of Two Large, Randomized, Controlled Trials.
Q64263307High Calcineurin Inhibitor Intrapatient Variability Is Associated With Renal Allograft Inflammation, Chronicity, and Graft Loss
Q55002551High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation.
Q49724111Immunosuppression Adherence in Stable Kidney Transplant Patients Converted From Immediate- to Prolonged-Release Tacrolimus in Clinical Practice: A Norwegian Study
Q38154197Immunosuppression and allograft rejection following lung transplantation: evidence to date
Q38653411Impact of intrapatient variability (IPV) in tacrolimus trough levels on long-term renal transplant function: multicentre collaborative retrospective cohort study protocol
Q38357915Intra-patient variability in tacrolimus exposure: causes, consequences for clinical management
Q42284001Letter to the Editor: Mobile Technology Can Improve Adherence and Lessen Tacrolimus Variability in Patients Receiving Kidney Transplants
Q33933936Medication adherence in the transition of adolescent kidney transplant recipients to the adult care
Q36327259Patient-reported non-adherence and immunosuppressant trough levels are associated with rejection after renal transplantation
Q34448814Prevalence and correlates of medication non-adherence among kidney transplant recipients more than 6 months post-transplant: a cross-sectional study
Q64097124Randomised controlled trial of a video intervention and behaviour contract to improve medication adherence after renal transplantation: the VECTOR study protocol
Q34852714Self-reported adherence to medications in a pediatric renal clinic: psychological aspects
Q53085840Sirolimus and tacrolimus coefficient of variation is associated with rejection, donor-specific antibodies, and nonadherence.
Q33694700Tacrolimus Blood Level Fluctuation Predisposes to Coexisting BK Virus Nephropathy and Acute Allograft Rejection
Q57466797Tacrolimus Trough and Dose Intra-Patient Variability and CYP3A5 Genotype: Effects on Acute Rejection and Graft Failure in European American and African American Kidney Transplant Recipients
Q55307350Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection.
Q89145695The Evolution of Lung Transplant Immunosuppression
Q34538633The TAKE-IT study: aims, design, and methods
Q33442355The TRANSNephro-study examining a new transition model for post-kidney transplant adolescents and an analysis of the present health care: study protocol for a randomized controlled trial.
Q44535101Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure
Q36359154Transitional Care and Adherence of Adolescents and Young Adults After Kidney Transplantation in Germany and Austria: A Binational Observatory Census Within the TRANSNephro Trial
Q38718380Understanding Medication Nonadherence after Kidney Transplant

Search more.